BUY Global Health Limited — Motilal Oswal
byMotilal OswalHorizon: NA (inferred 1 year)23 Jun 2026via CNBC Awaaz.
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
Global Health Shares Rise 2% as Q1 Revenue Grows 26%
NewsGoogle News·10 Aug · today
Global Health Ltd (Medanta) பங்கு விலை: வருவாய் 26% உயர்வு!
NewsGoogle News·5 Aug · 4d ago
Global Health Ltd (Medanta) शेअरमध्ये तेजी! पहिल्या तिमाहीत २६% उत्पन्न वाढले
NewsGoogle News·5 Aug · 4d ago
Global Health Ltd (Medanta) Q1 FY27 Income Rises 26% to ₹1,326 Crore
NewsGoogle News·5 Aug · 4d ago
Global Health Ltd (Medanta) के शेयर चमके! Q1 FY27 में आय में **26%** की उछाल, ₹1,326 करोड़ के पार
NewsGoogle News·5 Aug · 4d ago
Broker’s Call: Global Health (Hold)
NewsHbl·3 Aug · 6d ago
Global Health Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.
NSE · Outcome of Board Meeting·30 Jul · 1w ago
Outcome of Board Meeting held today i.e. July 30, 2026, to consider Unaudited Financial Results for Quarter ended June 30, 2026.
BSE · Board Meeting·30 Jul · 1w ago
Global Health Ltd approves 20,000 ESOPs for one employee
NewsGoogle News·30 Jul · 1w ago
Global Health: Approves 20,000 ESOPs Grant to One Employee
NewsGoogle News·30 Jul · 2w ago
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Global Health
- BUY — Jefferies India1 Oct 2026 · ~1 year · target ₹1,660 · Active
- BUY — Emkay Global1 Oct 2026 · ~1 year · target ₹1,500 · Active
- BUY — Deven Mehata, IDBI Capital Markets and Securities25 Sept 2026 · ~2 weeks · target ₹1,625 · SL hit
- BUY — Shrikant Chouhan, Kotak Securities24 Sept 2026 · ~3 months · target ₹1,700 · Active
- BUY — IDBI Capital22 Sept 2026 · ~2 weeks · target ₹1,610 · SL hit
More from Motilal Oswal
- BUY Colgate Palmolive (India)22 Oct 2026 · ~1 year · target ₹2,000 · Active
- BUY Sapphire Foods India22 Oct 2026 · ~1 year · target ₹245 · Active
- BUY CIE Automotive India22 Oct 2026 · ~1 year · target ₹440 · Active
- BUY CREDITACCESS GRAMEEN22 Oct 2026 · ~1 year · target ₹1,450 · Active
- BUY KEI Industries22 Oct 2026 · ~1 year · target ₹5,180 · Active

